UK markets closed

BioLargo, Inc. (BLGO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.3175-0.0095 (-2.91%)
At close: 03:08PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,574
-
5,884
2,531
2,432
Cost of revenue
2,359
-
3,027
1,428
1,204
Gross profit
2,215
-
2,857
1,103
1,228
Operating expenses
Research development
1,358
-
1,319
1,367
1,338
Selling general and administrative
6,253
-
6,731
6,172
7,473
Total operating expenses
7,530
-
7,913
7,464
8,563
Operating income or loss
-5,315
-
-5,056
-6,361
-7,335
Interest expense
68
-
53
234
1,923
Total other income/expenses net
-132
-
-23
-299
-442
Income before tax
-5,515
-
-5,132
-6,894
-9,700
Income from continuing operations
-5,515
-
-5,132
-6,894
-9,700
Net income
-5,910
-
-4,473
-7,080
-8,432
Net income available to common shareholders
-5,910
-
-4,473
-7,080
-8,432
Basic EPS
-0.02
-0.02
-0.02
-0.03
-0.05
Diluted EPS
-0.02
-0.02
-0.02
-0.03
-0.05
Basic average shares
282,363
285,957
268,302
247,204
195,994
Diluted average shares
282,363
285,957
268,302
247,204
195,994